Article in Infection and immunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
Journal of bacteriology · 2024
Review
Infection and immunity · 2024
Article
bioRxiv : the preprint server for biology · 2024
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors at 3 institutions in 1 country.
Charles N S AllenDepartment of Cell Biology and Molecular Genetics, University of Maryland , College Park, Maryland, USA.ORCID 0000-0003-4067-7596
Dallas A BanksDepartment of Cell Biology and Molecular Genetics, University of Maryland , College Park, Maryland, USA.
Michael ShusterDepartment of Cell Biology and Molecular Genetics, University of Maryland , College Park, Maryland, USA.
Stefanie N VogelDepartment of Microbiology and Immunology, University of Maryland School of Medicine , Baltimore, Maryland, USA.
Tamara J O'ConnorDepartment of Biological Chemistry, Johns Hopkins University School of Medicine , Baltimore, Maryland, USA.ORCID 0000-0003-2535-5820
Volker BrikenDepartment of Cell Biology and Molecular Genetics, University of Maryland , College Park, Maryland, USA.ORCID 0000-0001-5830-6107
University of Maryland, College Park · USJohns Hopkins University · USUniversity of Maryland, Baltimore · US
Funding
Macrophage differentiation and disease outcome in influenza infectionR01AI123371 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2017 to 2021
$2.7M
Training in Host-pathogens interactionsT32AI089621 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI LEE, VINCENT T, MCIVER, KEVIN S. · 2010 to 2025
$2.1M
A systematic method for Gain-of Function genetics in mycobacteriaR21AI151973 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BRIKEN, VOLKER, SASSETTI, CHRISTOPHER M · 2020 to 2021
$463k
Identification of Mycobacterium tuberculosis genes that mediate inhibition of the host cell IFN-beta signalingR21AI142396 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI BRIKEN, VOLKER · 2020 to 2021
The host type I interferon (IFN) response protects against
Indexed as
Interferon Type ILegionella pneumophilaLegionnaires' DiseaseHumansInterferon-gammaSignal TransductionType IV Secretion SystemsInterferon-gammaInterferon Type IType IV Secretion Systemsimmune evasioninterferonsLegionella pneumophilanitric oxidesecretion systems
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.